PT-141
A synthetic peptide (Bremelanotide) acting as a potent, non-selective agonist of the melanocortin receptors. Utilized to investigate central nervous system mechanisms of arousal via MC4R signaling.
RetaCagri (Retatrutide + Cagrilintide)
A proprietary co-formulation combining a triple GIP/GLP-1/GCGR agonist with a long-acting amylin analogue. Utilized to investigate profound, multi-receptor metabolic signaling and energy homeostasis.
Retatrutide
A highly complex synthetic peptide acting as a triple agonist of the GIP, GLP-1, and Glucagon (GCGR) receptors. Utilized to investigate multi-pathway metabolic regulation and energy expenditure models.
Semaglutide
A synthetic peptide engineered as a selective GLP-1 receptor agonist. Utilized to investigate incretin pathway activation, delayed gastric emptying models, and beta-cell function in preclinical studies.
Semax
A synthetic heptapeptide analogue derived from adrenocorticotropic hormone (ACTH 4-10). Utilized to investigate BDNF/NGF expression, neuroprotection, and cognitive pathway modulation.
SLU-PP-322 (Capsules)
A synthetic small molecule engineered as a highly selective pan-Estrogen Related Receptor (ERR) agonist. Utilized to investigate mitochondrial biogenesis, fatty acid oxidation, and exercise-mimetic signaling pathways.
TB500
A synthetic fraction of the naturally occurring peptide Thymosin Beta-4. Utilized to investigate actin-sequestering properties, cellular motility, and extracellular matrix remodeling.
Tesamorelin
A synthetic, N-terminally modified analogue of growth hormone-releasing hormone (GHRH). Utilized to investigate targeted visceral adipose reduction pathways and basal growth hormone pulsatility.
Tirzepatide (BEST PRICE ONLINE)
ALWAYS THE LOWEST PRICE ON THE HIGHEST QUALITY TIRZEPATIDE. A synthetic peptide engineered as a dual GIP and GLP-1 receptor agonist. Utilized to investigate synergistic incretin receptor binding and its effects on intracellular cAMP production.